Myths vs facts: Menopause Check and Wechseljahre

The question of myths vs. facts about menopause checks and 'Wechseljahre' is timely, as many commercial tests claim to predict menopause timing or symptom severity. However, the scientific evidence for DNA-based menopause tests is weak. While genome-wide association studies have identified variants near genes like MCM8 and TMEM150B that influence age at natural menopause, their effect sizes are small and explain only a fraction of the variance. No genetic test can accurately predict when an individual will enter menopause or how intense symptoms will be. Menopause is a complex, multifactorial process influenced by genetics, lifestyle, environment, and hormonal status. Clinically, blood markers such as FSH, estradiol, and AMH are far more informative for assessing ovarian reserve and menopausal stage. Many direct-to-consumer tests rely on weak associations and may give false reassurance. The reality is that menopause is highly individual, and a genetic test cannot replace proper hormonal diagnostics. Evidence for actionable recommendations from such tests is lacking. Consumers should be cautious of claims that a test can determine the ideal timing for family planning or hormone therapy.